Can a patient with a history of opioid use disorder, currently experiencing withdrawal symptoms on Suboxone (buprenorphine/naloxone) 8mg twice daily, be switched to a single daily dose of 24mg Suboxone (buprenorphine/naloxone)?

Switching to Single Daily 24mg Suboxone Dosing

Yes, you can safely switch from 8mg twice daily (16mg total) to a single daily dose of 24mg Suboxone, and this higher dose may actually improve treatment outcomes, particularly for patients with ongoing withdrawal symptoms or cravings. 1, 2

Pharmacological Rationale for Once-Daily Dosing

• Buprenorphine has a long duration of action (24-72 hours) due to its high receptor binding affinity and slow dissociation from mu-opioid receptors, making once-daily dosing pharmacologically appropriate 3, 1
• The standard maintenance dose is typically 16mg daily for most patients, with an effective range of 4-24mg 1
• Buprenorphine occupies approximately 95% of mu-opioid receptors at doses of 16mg and above, creating a ceiling effect for both therapeutic benefit and respiratory depression 1

Evidence Supporting 24mg Daily Dosing

• Recent prospective cohort data (2024) demonstrates that patients stabilized on 24-32mg daily had significantly better retention in treatment (78.7%) compared to those on lower doses (50.0%) 2
• Doses of 16mg or higher are required to achieve <20% mu-opioid receptor availability, which is necessary to block the reinforcing effects of typical doses of abused opioids 4
• For withdrawal suppression alone, lower doses may suffice (≤50% receptor availability), but higher doses provide superior blockade against relapse 4

Clinical Benefits of Dose Escalation to 24mg

• The 2024 study showed that increasing from 24mg to 32mg was associated with:
  • Significant decline in opioid use (68.5% to 59.5%, P=0.02) 2
  • Reduced frequency of use per week (1.58 to 1.15 times, P=0.0002) 2
  • Dramatic reduction in physiologic triggers for use (38.2% to 7.0%, P<0.0001) 2

Practical Implementation

• Simply administer the entire 24mg dose once daily in the morning, rather than splitting into twice-daily dosing 1
• The patient should take the medication sublingually and allow it to dissolve completely 1
• Monitor for withdrawal symptoms using the Clinical Opiate Withdrawal Scale (COWS) at follow-up visits 1

Safety Considerations

• Buprenorphine has a ceiling effect on respiratory depression, making doses up to 32mg safe even in accidental or intentional overdose 5
• The FDA prescribing information advises dosing up to 24mg/day, and doses up to 32mg have been shown to be safe and effective 2
• Screen for QT-prolonging medications, as concomitant use is contraindicated 1

Common Pitfalls to Avoid

• Do not discontinue or taper buprenorphine once started, as this precipitates withdrawal and dramatically increases relapse risk to more dangerous opioids 1, 6
• Do not confuse buprenorphine for opioid use disorder with buprenorphine for pain management—the former should never be reduced to comply with opioid dose guidelines due to its ceiling effect on respiratory depression 1
• Avoid rigid adherence to lower doses if the patient continues to experience withdrawal symptoms or cravings—higher doses are both safe and more effective 2

Duration of Treatment

• There is no maximum recommended duration of maintenance treatment—patients may require treatment indefinitely 1, 6
• Medication for addiction treatment has demonstrated effectiveness and saves lives, with better outcomes compared to referral only or brief intervention 1